spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  ischemia 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 31 Mar 2026
SirPAD: Primary Results Confirm the Safety and Efficacy of Sirolimus Coated Balloon in PAD
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2026
Bridge to Life Announces First Commercial Use of VitaSmart(TM) Hypothermic Oxygenated Perfusion (HOPE) System by Major U.S. Transplant Center Following FDA Clearance, Signaling Early Physician Confidence
Devices Surgery
 HSMN NewsFeed - 10 Feb 2026
Vesalio Expands International Neurovascular Portfolio with CE Mark of NeVa VS and NeVa 3.0 mm and Receives Additional FDA 510(k) Clearance for its Aspiration Catheters
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 15 Jan 2026
Boston Scientific announces agreement to acquire Penumbra, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 5 Jun 2025
Penumbra Introduces the Ruby(R) XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization
Devices Interventional FDA Product Launch
 HSMN NewsFeed - 3 Dec 2024
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
Devices Interventional Product Launch
 HSMN NewsFeed - 16 Sep 2024
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash(TM) 2.0 and Lightning Bolt(TM) 7 - in Europe
Devices Interventional Regulatory
 HSMN NewsFeed - 4 Sep 2024
Vesalio launches pVasc Thrombectomy System in the U.S. for peripheral occlusions
Devices Interventional Product Launch
 HSMN NewsFeed - 26 Mar 2024
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS(R)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 12 Mar 2024
Emboline Announces That the First One Hundred Patients Have Been Treated in the IDE Study of the Emboliner(R) Full-Body Embolic Protection Catheter to Minimize Stroke Risk From TAVR
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Feb 2024
Efemoral Medical Granted Breakthrough Device Designation
Devices Interventional FDA
 HSMN NewsFeed - 1 Jun 2023
Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration
Devices Interventional Product Launch FDA
 HSMN NewsFeed - 8 Aug 2022
Kodiak Sciences Reports Positive Topline Results from BEACON Phase 3 Study of Tarcocimab Tedromer (KSI-301) in Patients with Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 25 Apr 2022
MedTech Company STENTiT Raises €1.8 million in Seed Round
Devices Interventional Venture Capital
 HSMN NewsFeed - 12 Apr 2022
FDA Clears Four New Coronary Micro Support Catheters
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 25 Mar 2022
Sky Medical Technology wins further FDA clearance to market the new (W3) geko(TM) device variant for venous insufficiency and ischemia
Devices FDA
 HSMN NewsFeed - 14 Feb 2022
Advanced Oxygen Therapy: Announcing Key Leadership Team Additions and Scientific Clinical Advisory Board Formation
Devices Wound Care Personnel
 HSMN NewsFeed - 8 Feb 2022
FDA Approves JUVÉDERM(R) VOLBELLA(R) XC for Undereye Hollows
Devices Dermatology FDA
 HSMN NewsFeed - 11 Jan 2022
New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities
Devices Interventional
 HSMN NewsFeed - 8 Oct 2021
18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR(TM) Presented as Late Breaking Trial at VIVA
Devices Interventional
 HSMN NewsFeed - 22 Sep 2021
Dr. Thomas Serena, MD, FACS, FACHM, MAPWCA Has Agreed to be MDM Wound Ventures, Inc's Clinical and Research Director
Devices Wound Care Personnel
 HSMN NewsFeed - 17 Mar 2021
Next-Generation Microcatheter Platform Earns CE Mark Approval
Devices Interventional Regulatory
 HSMN NewsFeed - 1 Feb 2021
Marizyme, Inc. Strengthens Senior Management Team with Two Appointments: Roger Schaller EVP, Commercial Operations and Amy Chandler, EVP, Regulatory Affairs and Quality Management Systems
Devices Cardiology Surgery Personnel
 HSMN NewsFeed - 25 Jan 2021
PEDRA(TM) Technology Receives FDA Breakthrough Device Designation for its PEDRA(TM) Xauron(TM) Real-Time Tissue Perfusion System
Devices Monitoring FDA
 HSMN NewsFeed - 11 Jan 2021
Marizyme Announces the Use of DuraGraft(R) as the Standard-of-Care in Patients Undergoing Coronary Artery Bypass Surgery (CABG) at Vienna Heart Center North Floridsdorf
Devices Cardiology
 HSMN NewsFeed - 4 Dec 2020
Marizyme, Inc. Expands Executive Team, Board of Directors
Devices Surgery Cardiology Personnel
 HSMN NewsFeed - 9 Nov 2020
The world's largest RCT investigating use of MagicTouch PTA Sirolimus Coated balloon for peripheral artery disease kicks off to a flying start
Devices Interventional
 HSMN NewsFeed - 6 Nov 2020
Marizyme, Inc. Appoints Dr. Neil J. Campbell, as CEO, President and Member of Board of Directors
Devices Surgery Personnel
 HSMN NewsFeed - 3 Nov 2020
FDA Approves Updated Label for Endari(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Sep 2020
OrbusNeich(R) Announces China Approval for COMBO(R) Coronary Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 Aug 2020
Enrolment initiated in World's First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 21 Aug 2020
Cipla and Stempeutics collaborate for launch of Stempeucel(R), first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 12 May 2020
Micro Medical Solutions: First Case Completed in STAND Study, the Pivotal Clinical Trial of MicroStent
Devices Interventional
 HSMN NewsFeed - 12 May 2020
FDA Clears New XO Cross Microcatheter Platform
Devices Interventional FDA
 HSMN NewsFeed - 6 May 2020
FDA Clears New Mechanical Thrombectomy Platform
Devices Interventional FDA
 HSMN NewsFeed - 29 Jan 2020
CytoSorb(R) is Approved and Available for the Removal of Ticagrelor, a Leading Anti-Platelet Drug, During Cardiopulmonary Bypass in the E.U.
Devices Regulatory Product Launch
 HSMN NewsFeed - 28 Jan 2020
Profusa Receives CE Mark Approval to Market the Wireless Lumee(R) Oxygen Platform for Continuous, Real-Time Monitoring of Tissue Oxygen
Devices Monitoring Regulatory
 HSMN NewsFeed - 2 Oct 2019
Upsher-Smith Laboratories Launches Tosymra(TM) (sumatriptan) Nasal Spray For The Acute Treatment Of Migraine In Adults
Biopharmaceuticals Neurology Drug Delivery Product Launch
 HSMN NewsFeed - 25 Sep 2019
OrbusNeich(R) Announces Japan Approval for COMBO(R) Plus Coronary Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 24 Sep 2019
Emmaus Life Sciences Reinforces Positive Outcomes of Endari(R) Clinical Trials, Including Efficacy Findings That Led to FDA Approval
Biopharmaceuticals
 HSMN NewsFeed - 20 Sep 2019
CHMP Issues Positive Opinion to Expand Trulicity(R) (dulaglutide) Label to Include Results from REWIND Cardiovascular Outcomes Trial
Biopharmaceuticals Endocrinology Cardiology Regulatory
 HSMN NewsFeed - 3 Sep 2019
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
Biopharmaceuticals Devices Dermatology FDA
 HSMN NewsFeed - 24 Jun 2019
Micro Medical Solutions Receives FDA IDE Approval for Pivotal Clinical Trial of MicroStent
Devices Interventional FDA
 HSMN NewsFeed - 14 May 2019
John Fletcher Named Strategic Advisor to Micro Medical Solutions
Devices Interventional Personnel
 HSMN NewsFeed - 21 Dec 2018
Mallinckrodt And NPXe Announce First Patient Enrolled In Phase 3 Trial Of Inhaled Xenon Gas Therapy
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 11 Dec 2018
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer(TM) as Published in JACC
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Dec 2018
LumiThera Announces a Distribution Agreement for the Valeda Light Delivery System with Miloftalmica in Italy
Devices Ophthalmology Distribution
 HSMN NewsFeed - 7 Dec 2018
Contego Medical Receives 510(k) Clearance for the Vanguard IEP Peripheral Angioplasty System with Integrated Embolic Protection
Devices Interventional FDA
 HSMN NewsFeed - 1 Oct 2018
FDA Approves KYPROLIS(R) (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone (Kd70) For Patients With Relapsed Or Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Sep 2018
Cablivi(TM) (caplacizumab) approved in Europe for adults with acquired thrombotic thrombocytopenic purpura (aTTP)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Jun 2018
Mercator MedSystems Receives $11M in Series D Equity Financing Led by Shenzhen Salubris Pharmaceuticals Co.
Devices Interventional Venture Capital
 HSMN NewsFeed - 12 Dec 2017
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 12 Dec 2017
Eyevensys Appoints Dr. Patricia Zilliox as Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 31 Oct 2017
BRH Medical Receives FDA Clearance for its Patented BRH-A2 Combined Ultrasound and Electric Field Stimulation Device
Devices Wound Care FDA
 HSMN NewsFeed - 3 Aug 2017
VM BioPharma Announces First Patient Dosed in Phase 3 Study of Gene Therapy Candidate VM202 for Non-Healing Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 31 May 2017
Lilly Announces Phase 3 RANGE Urothelial Cancer Trial of CYRAMZA(R) (ramucirumab) Met Primary Endpoint, Improving Progression-Free Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2017
Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Apr 2017
Contego Medical Receives CE Mark for Vanguard IEP(TM) Peripheral Balloon Angioplasty System with Integrated Embolic Protection
Devices Interventional Regulatory
 HSMN NewsFeed - 26 Apr 2017
Mercator MedSystems Announces First Enrollment in the TANGO Trial for BTK Vascular Disease
Devices Interventional Drug Delivery
 HSMN NewsFeed - 13 Feb 2017
Intact Vascular's Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) Clinical Trial Commences Enrollment with First Implant of the Tack Endovascular System(R)
Devices Interventional
 HSMN NewsFeed - 8 Nov 2016
BRH Medical Receives Patents in Both the USA and in China for Its Innovative Wound Healing Therapy
Devices Wound Care
 HSMN NewsFeed - 10 Oct 2016
St. Jude Medical Announces FDA Clearance and Launch of the New PressureWire X Guidewire Designed to Optimize PCI Procedures in Patients With Complex Anatomies
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 10 Oct 2016
First Positive Phase 3 Results in Adjuvant Setting for Renal Cell Carcinoma Show SUTENT(R) (sunitinib) Extended Disease Free Survival After Surgical Removal
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Sep 2016
FDA Approves New AGGRASTAT(R) Product Format
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 29 Jul 2016
Edge Therapeutics Announces First Patient Treated in Phase 3 NEWTON 2 Study of EG-1962 in Adult Patients with Aneurysmal Subarachnoid Hemorrhage
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 4 Jul 2016
European Commission Approves Extended Indication For Amgen's Kyprolis(R) (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma Patients
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 May 2016
St. Jude Medical Announces European Launch of the Latest in PressureWire Guidewire Technology to Measure Pressure Differences Across Narrowed Coronary Arteries
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 11 May 2016
Medicure Files Application for New AGGRASTAT(R) Product Format
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 2 May 2016
Corsens Medical Ltd., Announces Filing of a 510(k) Pre-Marketing Notification with the US Food and Drug Administration for the Corsens Cardiac Monitor
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 25 Mar 2016
Hemostemix Appoints Hardean E. Achneck, M.D. as Chief Medical Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 8 Feb 2016
STENTYS initiates the Commercialization of the first Self-Expanding Drug-Eluting stent for the Below-The-Knee Indication
Devices Interventional Product Launch
 HSMN NewsFeed - 3 Feb 2016
Emmaus Life Sciences Announces Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jan 2016
Michael Martino Named President and Chief Executive Officer of HemaFlo Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2015
Cesca Receives Approval for Medicare Coverage
Regenerative Medicine Reimbursement
 HSMN NewsFeed - 2 Nov 2015
Bristol-Myers Squibb to Acquire Cardioxyl Pharmaceuticals, Inc.
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 1 Oct 2015
U.S. FDA Approves JUVEDERM(R) ULTRA XC for Use in Lips
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 12 Aug 2015
Japan Grants Safety Clearance to Pluristem's PLX-PAD Cells for Use in Clinical Trials
Regenerative Medicine Regulatory
 HSMN NewsFeed - 20 Apr 2015
Cardiovascular Systems Receives FDA Clearance for New Peripheral Diamondback Device
Devices Interventional FDA
 HSMN NewsFeed - 13 Apr 2015
Actavis and Medicines360 Announce U.S. Availability of LILETTA(TM) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 11 Nov 2014
BioCardia(R), Inc. Announces FDA Acceptance of Phase III Clinical Trial Protocol Studying Bone Marrow-Derived Cell Therapy for Heart Failure Patients
Regenerative Medicine Cardiology FDA
 HSMN NewsFeed - 24 Oct 2014
The TransMedics(R) Organ Care System (OCS(TM)) Heart Technology Was Used to Perform The World's First Series of Adult Human Heart Transplants From Donors After Circulatory Death (DCD Donors) at St Vincent's Hospital in Sydney, Australia
Devices Cardiology
 HSMN NewsFeed - 16 Oct 2014
FDA Approves Boehringer Ingelheim's OFEV(R) (nintedanib) as First Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Aug 2014
Boston Therapeutics Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. to Its Medical Advisory Board
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 5 Aug 2014
Boston Therapeutics Expands Medical Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jul 2014
Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR(R) (sorafenib) in Patients with Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Jul 2014
Bioheart Announces World's First Combination Stem Cell Treatment
Regenerative Medicine Cardiology
 HSMN NewsFeed - 30 Jun 2014
Flamel Technologies Announces FDA Approval of VAZCULEP
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Jun 2014
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Apr 2014
Endo Acquires Rights to Sumavel(R) DosePro(R)
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 15 Apr 2014
AAVLife Raises $12 Million in Series A Financing to Advance Gene Therapy for Friedreich’s Ataxia
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 26 Mar 2014
Cesca Therapeutics Submits pre-IDE Information Package to FDA for Surgwerks(TM) CLI therapy System
Regenerative Medicine FDA
 HSMN NewsFeed - 17 Mar 2014
BioCardia(R) Receives CE Mark for Morph AccessPro(TM) Steerable Introducer
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 12 Mar 2014
Cardiovascular Systems Announces First Peripheral Arterial Disease Case Treated with New, Low-Profile, 60cm Diamondback Peripheral System
Devices Interventional
 HSMN NewsFeed - 12 Mar 2014
Toshiba’s Exclusive CT Myocardial Perfusion Helps Produce Faster and Safer Cardiac Diagnoses
Devices Radiology Cardiology FDA
 HSMN NewsFeed - 11 Mar 2014
Bayer and Onyx Report Phase 3 Study Results of NEXAVAR(R) (sorafenib) as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Mar 2014
Cardiovascular Systems Receives FDA Clearance for Low Profile, 60cm Diamondback Devices Designed to Expand the Treatment of Peripheral Artery Disease (PAD)
Devices Interventional FDA
 HSMN NewsFeed - 25 Feb 2014
Boston Therapeutics Appoints Larry K. Ellingson, Former Chair of the American Diabetes Association, as Chair of Its Scientific Advisory Board
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 20 Feb 2014
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Colorectal Cancer after Resection of Liver Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Feb 2014
Medtronic Launches 'TOTAL Across' Crossing Catheter in Europe
Devices Interventional Product Launch
 HSMN NewsFeed - 10 Feb 2014
Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Feb 2014
Covis Pharmaceuticals Announces Its New Expanded Dosage Options of LANOXIN(R) for Cardiac Patients With Mild-to-Moderate Heart Failure
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 29 Jan 2014
Bioheart Announces First Adipose Derived Stem Cell Implantation in Azerbaijan
Regnerative Medicine
 HSMN NewsFeed - 28 Jan 2014
Nonin Medical Announces United Kingdom and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart(TM) Universal Oximetry System
Devices Monitoring Distribution
 HSMN NewsFeed - 14 Jan 2014
ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme(TM) Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Dec 2013
Baxter Receives FDA Approval of FEIBA [Anti-Inhibitor Coagulant Complex] for Prophylactic Treatment of Hemophilia A&B Patients with Inhibitors
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Dec 2013
America Stem Cell, Inc. Changes Its Name to Targazyme, Inc.
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 10 Dec 2013
Boston Therapeutics Appoints Three to Management Positions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Nov 2013
FDA Approves Varithena(TM) (Polidocanol Injectable Foam) for the Treatment of Patients with Varicose Veins
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Oct 2013
Bioheart Announces Agreement With Anosis to Distribute Products in the Middle East
Regenerative Medicine Cardiology Distribution
 HSMN NewsFeed - 17 Oct 2013
Health Canada Approves A New Treatment Option For Patients With Gastrointestinal Stromal Tumours (GIST), A Rare Form Of Sarcoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 9 Oct 2013
First Patient Enrolled in Phase III Trial Evaluating The Medicines Company's Angiomax(R) (Bivalirudin) in Patients Undergoing Peripheral Endovascular Procedures
Biopharmaceuticals Interventional
 HSMN NewsFeed - 8 Oct 2013
Terumo Interventional Systems Launches The Detachable AZUR(R) CX Peripheral Coil System
Devices Interventional Product Launch
 HSMN NewsFeed - 24 Sep 2013
FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) Arteries
Devices Interventional FDA
 HSMN NewsFeed - 4 Sep 2013
New Data Suggests Abbott's High Sensitive Troponin Test May Help Doctors More Accurately Diagnose Heart Attacks in Women
Diagnostics Cardiology
 HSMN NewsFeed - 30 Aug 2013
Bayer's Stivarga(R) (regorafenib) Tablets Approved in Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 28 Aug 2013
Sheldon T. Anderson Elected to the Board of Directors of Bioheart, Inc.
Regenerative Medicine Cardiology Personnel
 HSMN NewsFeed - 21 Aug 2013
Abbott Completes Acquisition of IDEV Technologies
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 6 Aug 2013
First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich's COMBO Dual Therapy Stent(TM) in Routine Practice
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Jul 2013
Multicenter Study Finds Cost Savings Associated With Coronary Interventions Via Transradial (Wrist) Access Exceed $800 Per Procedure Versus Transfemoral (Groin) Access
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Jul 2013
Boston Scientific Launches OptiCross(TM) Coronary Imaging Catheter in U.S., Europe and Japan
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 15 Jul 2013
Abbott to Acquire IDEV Technologies to Expand Global Peripheral Technology Portfolio
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 26 Jun 2013
Pluristem Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech for the Development and Commercialization of PLX Cells for the Treatment of CLI and IC in South Korea
Regenerative Medicine Licensing
 HSMN NewsFeed - 4 Jun 2013
Edge Therapeutics Raises $18 Million to Advance Clinical Development of Potentially Life-Saving Hospital Products
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 May 2013
OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2013
OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2013
St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 15 May 2013
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Advanced Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Apr 2013
Terumo Cardiovascular Systems Announces U.S. Distribution Agreement with Nonin Medical for Nonin's EQUANOX(TM) 7600 Regional Oximetry System
Devices Monitoring Distribution
 HSMN NewsFeed - 27 Mar 2013
Bioheart's Appeals to the FDA for Compassionate Use Designation to Save Lives
Regenerative Medicine Cardiology FDA
 HSMN NewsFeed - 19 Mar 2013
Bioheart Expands Center of Excellence Program
Regenerative Medicine Cardiology
 HSMN NewsFeed - 15 Mar 2013
Novadaq Announces Termination of Agreements With KCI
Devices Wound Care
 HSMN NewsFeed - 12 Mar 2013
Boston Therapeutics Appoints Peter Sheehan, M.D. as Medical Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Mar 2013
St. Jude Medical Announces Launch of 3-D Vessel Reconstruction Technology in Japan
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Mar 2013
Boston Scientific Launches Rubicon(TM) Support Catheter in 0.035" and 0.018" Diameters
Devices Interventional Product Launch
 HSMN NewsFeed - 28 Feb 2013
ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"
Biopharmaceuticals
 HSMN NewsFeed - 25 Feb 2013
Intravase(R) Approval Opens Vascular Market for Cytori
Regenerative Medicine FDA
 HSMN NewsFeed - 29 Jan 2013
Spectranetics Announces Expansion Into Japan Peripheral Intervention Market
Devices Interventional Regulatory
 HSMN NewsFeed - 25 Jan 2013
AngioScore Launches New 100 mm Length AngioSculpt(R) Scoring Balloons For Treatment of Peripheral Artery Disease Below The Knee (BTK)
Devices Interventional Product Launch
 HSMN NewsFeed - 24 Jan 2013
Final Results of Spectranetics Study Supports Successful Use of Laser Atherectomy for Treating Patients With Peripheral In-Stent Restenosis
Devices Interventional
 HSMN NewsFeed - 9 Jan 2013
Ischemix, Inc. Appoints New Chief Executive Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 3 Jan 2013
Phase 3 DECISION Trial of Nexavar(R) (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival in Patients with Radioactive Iodine Refractory Differentiated Thyroid Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Dec 2012
John Norris, JD, MBA Appointed CEO of Health Discovery Corporation
Diagnostics Personnel Personalized Medicine
 HSMN NewsFeed - 21 Dec 2012
FDA Approves Gattex(R) (teduglutide [rDNA Origin]) for Injection for the Treatment of Adult Short Bowel Syndrome
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 19 Dec 2012
Regado Biosciences, Inc. Secures $51 Million Series E Financing
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 18 Dec 2012
St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Dec 2012
Angel Medical Systems, Inc. Completes Initial Closing of $27.5 Million Financing
Devices Cardiology Monitoring Venture Capital Personnel
 HSMN NewsFeed - 14 Nov 2012
New 10 cm GORE(R) Hybrid Vascular Graft Delivers Unprecedented Versatility
Devices Interventional
 HSMN NewsFeed - 13 Nov 2012
Boston Therapeutics Names Jonathan B.Rome Chief Operating Officer
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 29 Oct 2012
Bayer's Stivarga(R) (regorafenib) Tablets New Drug Application Granted Priority Review by U.S. FDA for the Treatment of Patients with Gastrointestinal Stromal Tumors
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Oct 2012
Bioheart to Initiate ANGEL Trial in Mexico
Regenerative Medicine Cardiology
 HSMN NewsFeed - 23 Oct 2012
The Boston Scientific PROMUS Element(TM) Platinum Chromium Stent Demonstrates Positive Outcomes in Patients with Long Coronary Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Oct 2012
First Patient Treated in Cytori’s U.S. Cell Therapy Heart Failure Trial
Regenerative Medicine Cardiology
 HSMN NewsFeed - 9 Oct 2012
Boston Scientific Launches Victory Guidewire For Crossing Resistant Lesions In Peripheral Arteries
Devices Interventional
 HSMN NewsFeed - 9 Oct 2012
Biopharmaceutical Executive Dr. Alan Lewis Appointed as CEO of Medistem
Regenerative Medicine Personnel
 HSMN NewsFeed - 4 Oct 2012
Boston Therapeutics Wins FDA Approval to File an Abbreviated New Drug Application for PAZAMET(TM) to Treat Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 27 Sep 2012
Bayer's Stivarga(R) (regorafenib) Tablets Approved by U.S. FDA for Treatment of Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Sep 2012
Ventrus Biosciences Appoints JP Benya Vice President, Commercial Operations and Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2012
Third Critically Ill Patient Successfully Treated With Pluristem's PLX Cells Under Compassionate Use
Regenerative Medicine Oncology
 HSMN NewsFeed - 4 Sep 2012
Revestive(R) (teduglutide) Receives European Marketing Authorization for the Treatment of Adults with Short Bowel Syndrome (SBS)
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 7 Aug 2012
Abbott's Omnilink Elite(R) Vascular Balloon-Expandable Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 6 Aug 2012
Life of Cancer Patient Suffering From Bone Marrow Failure Saved Following Treatment With Pluristem's PLX Cells
Regenerative Medicine Oncology
 HSMN NewsFeed - 23 Jul 2012
Addition of Tarceva(R) (erlotinib) to Nexavar(R) (sorafenib) did not Provide Additional Benefit to Patients with Unresectable Liver Cancer Versus Nexavar alone in Phase 3 Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Jul 2012
Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis(TM) (carfilzomib) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Jun 2012
Takeda Receives Positive CHMP Opinion for Teduglutide (Revestive(R)) for Patients with Short Bowel Syndrome
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 22 May 2012
Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2012
One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY(TM) Stent Versus PROMUS Element(TM) Platinum Chromium Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 10 May 2012
Cardionovum(R) Will Launch Two Drug-Eluting Balloon (DEB) Dilatation Catheter Product Families at EuroPCR 2012
Devices Interventional Cardiology
 HSMN NewsFeed - 7 May 2012
Kerberos to Sell FDA Cleared Rinspiration Technology
Devices Interventional Cardiology
 HSMN NewsFeed - 2 May 2012
Angioslide Announces FDA 510(K) Clearance of PROTEUS(TM) Below The Knee Device
Devices Interventional FDA
 HSMN NewsFeed - 16 Apr 2012
St. Jude Medical Announces CE Mark Approval of Smaller ICD with Physician-Inspired Shape
Devices Cardiology Regulatory
 HSMN NewsFeed - 13 Apr 2012
Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study
Devices Interventional
 HSMN NewsFeed - 6 Apr 2012
Arteriocyte Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors
Devices Orthopaedic FDA
 HSMN NewsFeed - 23 Mar 2012
St. Jude Medical Announces Next-Generation PressureWire for FFR Measurement
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 14 Mar 2012
Aastrom Biosciences Appoints Dr. LaVonne Lang as Head of Regulatory Affairs
Regenerative Medicine Personnel
 HSMN NewsFeed - 28 Feb 2012
Baxter Initiates Phase III Adult Stem Cell Clinical Trial for Chronic Cardiac Condition
Regenerative Medicine Cardiology
 HSMN NewsFeed - 28 Feb 2012
Miracor receives $3.5 million cash infusion to begin pivotal clinical “RAMSES” trial of its PICSO system, designed to improve myocardial perfusion following primary PCI
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Feb 2012
Bioheart Announces University of Miami as Clinical Site for ANGEL Trial of LipiCell(TM)
Regenerative Medicine Cardiology
 HSMN NewsFeed - 14 Feb 2012
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
Regenerative Medicine Cardiology
 HSMN NewsFeed - 7 Feb 2012
Lyndon B. Johnson General Hospital First to use PICO* Single Use Negative Pressure Wound Therapy System from Smith & Nephew
Devices Wound Care
 HSMN NewsFeed - 2 Feb 2012
Spectranetics Announces Interim Results from German Study Treating Patients with Peripheral In-Stent Restenosis
Devices Interventional
 HSMN NewsFeed - 30 Jan 2012
Cytori Receives Approval From FDA to Initiate U.S. Cardiac Cell Therapy Trial; Investigational Device Exemption (IDE) Approved for ATHENA
Regenerative Medicine Cardiology
 HSMN NewsFeed - 23 Jan 2012
FzioMed Receives CE Mark for DYNAVISC(R) Gel
Devices Surgery Regulatory
 HSMN NewsFeed - 18 Jan 2012
Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis
Devices Cardiology
 HSMN NewsFeed - 5 Jan 2012
Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen(TM) in South Korea
Devices Wound Care Distribution
 HSMN NewsFeed - 22 Dec 2011
Abbott Initiates Clinical Trial to Study Drug Eluting Bioresorbable Therapy for Treatment of Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 21 Dec 2011
TriReme Medical, Inc. Receives FDA 510(K) Clearance for Chocolate PTA Balloon Catheter
Devices Interventional FDA
 HSMN NewsFeed - 8 Dec 2011
Abbott Initiates Clinical Trial to Evaluate the Absorb(TM) Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Dec 2011
Spectros Corporation Signs Distribution Agreements in Middle East
Devices Monitoring Distribution
 HSMN NewsFeed - 1 Dec 2011
Covidien's Embolic Protection Device Receives FDA Clearance
Devices Interventional FDA
 HSMN NewsFeed - 14 Nov 2011
Athersys Announces Recovery of All Rights to Cardiovascular Cell Therapy Program
Regenerative Medicine Cardiology
 HSMN NewsFeed - 3 Nov 2011
Pluristem Announces Positive 12-Month Data From the Use of PLX-PAD for the Treatment of Critical Limb Ischemia
Regenerative Medicine
 HSMN NewsFeed - 26 Oct 2011
St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System
Devices Cardiology FDA
 HSMN NewsFeed - 14 Oct 2011
NovaBay Pharmaceuticals Spotlights NeutroPhase(R) at the Symposium on Advanced Wound Care (SAWC)
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 12 Oct 2011
Onyx Pharmaceuticals and Bayer Healthcare Restructure Global Oncology Partnership
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Oct 2011
FDA Approves Combivent(R) Respimat(R) (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Oct 2011
Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After Surgery
Devices Surgery Monitoring
 HSMN NewsFeed - 8 Sep 2011
Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia
Devices
 HSMN NewsFeed - 31 Aug 2011
St. Jude Medical Begins U.S. Trial Studying ST Segment Monitoring Technology
Devices Cardiology Monitoring
 HSMN NewsFeed - 26 Aug 2011
Medistem Submits Response to FDA Clinical Hold
Regenerative Medicine FDA
 HSMN NewsFeed - 18 Jul 2011
OrbusNeich's Genous Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Jul 2011
St. Jude Medical Announces European Approval of First and Only Combined FFR and OCT System
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jun 2011
St. Jude Medical Announces Japanese Launch of Smaller, Higher Power ICD and CRT-D Devices
Devices Cardiology Regulatory
 HSMN NewsFeed - 13 Jun 2011
Spectros Corporation Introduces Continuum(R), a Broadband Infrared Sensor for Brain and Gut Oximetry
Devices Monitoring
 HSMN NewsFeed - 13 Jun 2011
Pathway Medical Technologies Expands JETSTREAM G3 SF Family With FDA 510(k) Clearance for 1.6 mm Catheter
Devices Interventional FDA
 HSMN NewsFeed - 20 May 2011
PROMUS Element Stent Demonstrates Exceptional Safety and Effectiveness in PLATINUM Small Vessel Study
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2011
Cost Effectiveness Study Determines FFR Can Improve Health while Reducing Economic Burden in UK, France and Italy
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Apr 2011
St. Jude Medical Sponsored Study Determines FFR Can Improve Health while Reducing Economic Burden to German Healthcare System
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Apr 2011
Sangart Announces Closing of $50 Million Series G Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Apr 2011
Devon Medical Products Receives FDA 510(k) Clearance for ArterioFlow(TM) Pump that Treats Diabetic Foot, Peripheral Arterial Disorders
Devices FDA
 HSMN NewsFeed - 4 Apr 2011
Boston Scientific's Promus Element Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Mar 2011
VICTRELIS(TM) (boceprevir), Merck's Investigational Medicine, Added to Peginterferon Alfa-2a and Ribavirin Achieved Significantly Higher SVR Rates In Treatment-Failure Patients with Chronic HCV Genotype 1 Compared to Control
Biopharmaceuticals
 HSMN NewsFeed - 21 Mar 2011
Cordis Demonstrates Commitment to Advancing Therapies for Below-the-Knee Vascular Disease
Devices Interventional
 HSMN NewsFeed - 24 Feb 2011
Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Feb 2011
ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Jan 2011
GATTEX(R) (teduglutide) Meets Primary Efficacy Endpoint in Phase 3 Pivotal Study in Patients with Adult Short Bowel Syndrome
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 26 Jan 2011
Bristol-Myers Squibb and sanofi-aventis Announce U.S. FDA Decision to Grant Pediatric Exclusivity For PLAVIX
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 10 Jan 2011
Bioheart Reports Positive Results for Adipose Derived Stem Cells in Critical Limb Ischemia
Regenerative Medicine Wound Care
 HSMN NewsFeed - 7 Jan 2011
BioCardia elects Industry Veteran, Jay M. Moyes, to Board of Directors
Devices Regenerative Medicine Cardiology Personnel
 HSMN NewsFeed - 6 Jan 2011
CardioInsight Technologies Closes Financing and Secures Japanese Distribution Agreement
Devices Cardiology Distribution
 HSMN NewsFeed - 16 Dec 2010
Economic Evaluation of FAME Trial Confirms Using FFR in Treatment of Coronary Artery Disease Is Cost-Effective
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Dec 2010
Spinal Cord Injury Patient Treated With Non-Matched Adult Stem Cells
Regenerative Medicine Neurology
 HSMN NewsFeed - 7 Dec 2010
Medistem Announces New Management Team
Regenerative Medicine Personnel
 HSMN NewsFeed - 6 Dec 2010
Sangart, Inc. Announces Cooperative Research and Development Agreement With the U.S. Navy to Evaluate MP4 Molecule in Traumatic Brain Injury
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 Nov 2010
BioCardia Announces CE Mark Approval of the First Stand-alone Intramyocardial Stem Cell Delivery Catheter System
Devices Cardiology Regenerative Medicine Regulatory
 HSMN NewsFeed - 15 Nov 2010
Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 9 Nov 2010
Miracor reports successful first-in-man clinical outcome for its PICSO(R) system designed to improve acute coronary syndrome (ACS) revascularization following primary percutaneous coronary intervention (PCI)
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Oct 2010
Aldagen Announces Appointment of Lyle A. Hohnke, Ph.D. as Chief Executive Officer
Regenerative Medicine Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Sep 2010
DecImmune Therapeutics Secures $3.2 Million in Development Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Sep 2010
Abbott's XIENCE V(R) Shows Outstanding Two-Year Clinical Results Versus TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Boston Scientific's TAXUS(R) Element Stent Demonstrates Strong Outcomes in Diabetic Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Sep 2010
Cardiogenesis Comments on the STAR-Heart Study Presented at European Society of Cardiology (ESC) 2010 Congress
Regenerative Medicine Devices Cardiology
 HSMN NewsFeed - 31 Aug 2010
New 2010 ESC Guidelines for Percutaneous Coronary Interventions Reinforce Importance of FFR in Treatment of Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Aug 2010
Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial
Regenerative Medicine
 HSMN NewsFeed - 21 Jun 2010
Boston Scientific Expands PolarCath(R) Peripheral Dilatation System With New Balloon Sizes
Devices Interventional
 HSMN NewsFeed - 21 Jun 2010
Pathway Medical Technologies Receives FDA 510(k) Clearance for JETSTREAM G3 SF Atherectomy System
Devices Interventional FDA
 HSMN NewsFeed - 14 Jun 2010
Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jun 2010
Scott C. Durbin Joins Aastrom as Chief Financial Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 27 May 2010
CORDIS Launches ExoSeal(TM) Vascular Closure Device
Devices Interventional
 HSMN NewsFeed - 25 May 2010
Abbott's Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
St. Jude Medical Enrolls First Patient in FAME II Clinical Trial to Study Use of Fractional Flow Reserve Technology in Patients With Stable Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2010
Aastrom Announces Senior Management Appointments
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 17 May 2010
First Patient Treated in Aastrom's U.S. Phase 2 Catheter Clinical Trial in Dilated Cardiomyopathy
Regenerative Medicine Interventional Cardiology
 HSMN NewsFeed - 6 May 2010
The New England Journal of Medicine Publication of SPIRIT IV Trial Results Confirm Superior Safety and Efficacy of Abbott's XIENCE V(R) Drug Eluting Stent Compared to TAXUS
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Apr 2010
Bioheart Commenced Successful Regenerative Stem Cell Treatments with Latin American Patients Having Congestive Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 13 Apr 2010
Entest Biomedical Announces Intent to Acquire Medistem
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 17 Mar 2010
The Medicines Company Expands a Nationwide Recall for Certain Lots of Cleviprex(R) That May Contain Particulate Matter
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 16 Mar 2010
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Mar 2010
Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the CYPHER(R) Sirolimus Drug-Eluting Stent over the Endeavor(R) Zotarolimus-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Mar 2010
PERSEUS Trial Results Demonstrate Positive Safety and Efficacy Outcomes for Boston Scientific's Novel Platinum Chromium TAXUS(R) Element(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Mar 2010
Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care
Devices Cardiology Monitoring
 HSMN NewsFeed - 15 Mar 2010
St. Jude Medical Announces Multiple Enhancements to Industry-Leading PressureWire FFR Measurement System
Devices Monitoring Cardiology
 HSMN NewsFeed - 9 Mar 2010
Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial
Regenerative Medicine Cardiology
 HSMN NewsFeed - 23 Feb 2010
Aldagen Announces Strategic Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Feb 2010
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of Delayed Graft Function in Kidney Transplant Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Feb 2010
CoAxia Announces Completion of Enrollment in Ischemic Stroke Trial
Devices Interventional Neurology
 HSMN NewsFeed - 11 Feb 2010
OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Feb 2010
Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 4 Feb 2010
Bioheart Launches First US FDA Approved Clinical Trial that Tests Gene-Modified Stem Cell Therapy in Patients with Congestive Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 4 Feb 2010
St. Jude Medical Announces European Approval of Smaller, Higher Power ICD and CRT-D Devices with New Heart Failure Monitors
Devices Cardiology
 HSMN NewsFeed - 29 Jan 2010
Invatec Comments on First Clinical Results of Drug Eluting Balloon Technology for Below the Knee (BtK)
Devices Interventional
 HSMN NewsFeed - 26 Jan 2010
Cardium Provides Update on Commercial Development Plans for Generx Angiogenic Therapy for Heart Disease at 2010 Cell & Gene Therapy Forum
Biopharmaceuticals Cardiology Regenerative Medicine
 HSMN NewsFeed - 20 Jan 2010
SANUWAVE Appoints Dr. Maria Siemionow of Cleveland Clinic to Its Scientific Advisory Board
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 5 Jan 2010
Bioheart Inks Deals with Distributors to Introduce Home Heart Failure Monitoring Systems Throughout the U.S.
Devices Cardiology Monitoring Distribution
 HSMN NewsFeed - 5 Jan 2010
NewCardio, Inc. Announces Successful Clinical Studies Validating CardioBip Technology
Devices Cardiology Monitoring
 HSMN NewsFeed - 22 Dec 2009
Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Dec 2009
Importance of FFR in Treatment of Coronary Artery Disease Confirmed by New PCI Guidelines
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Nov 2009
VIVA 2009 Late-Breaking Trials Highlight Advances in Interventional Treatments of Peripheral Arterial Disease
Devices Interventional
 HSMN NewsFeed - 3 Nov 2009
First Device Designed to Preserve Blood Flow to Iliac Arteries During Aneurysm Repair Receives Approval from Health Canada
Devices Interventional Regulatory
 HSMN NewsFeed - 23 Oct 2009
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Oct 2009
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Sep 2009
Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Sep 2009
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents Compared to Bare-Metal Stents in Heart Attack Patients at Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Sep 2009
Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2009
FAME Trial Two-Year Follow-Up Results Demonstrate Continued Reduction in Risk of Death or Heart Attack When Physicians Use St. Jude Medical Fractional Flow Reserve Technology Prior to Implanting Coronary Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2009
Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2009
Pluristem Therapeutics Doses First Patient in U.S. With Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
Regenerative Medicine
 HSMN NewsFeed - 14 Sep 2009
Abbott Announces Approval in China for Next-Generation XIENCE V(R) Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 10 Sep 2009
Pluristem Begins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
Regenerative Medicine
 HSMN NewsFeed - 3 Sep 2009
Aastrom Announces Transitions in Senior Management
Regenerative Medicine Personnel
 HSMN NewsFeed - 31 Aug 2009
sanofi-aventis: Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Aug 2009
Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Aug 2009
Health Canada Approves Abbott's XIENCE V(R) Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 10 Aug 2009
Pathway Medical Technologies Introduces Jetstream G2 NXT
Devices Interventional
 HSMN NewsFeed - 30 Jul 2009
Cardiogenesis Corporation Makes Pre-IDE Submission for PHOENIX Combination Delivery System
Devices Cardiology
 HSMN NewsFeed - 22 Jul 2009
Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Jun 2009
CoAxia, Inc. Announces $21.5M Series D Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 16 Jun 2009
Pluristem Therapeutics Receives European Regulatory Approval for Placental-Derived Stem Cell Clinical Trial
Regenerative Medicine
 HSMN NewsFeed - 12 Jun 2009
BARI 2D Study Presented at American Diabetes Association Scientific Sessions Underscores Utility of SPECT Myocardial Perfusion Imaging in Identifying Cardiovascular Risk and Evaluating Treatment Outcomes for Patients with Type 2 Diabetes
Biopharmaceuticals Radiology Cardiology
 HSMN NewsFeed - 8 Jun 2009
Nonin Medical Introduces Next-Generation Regional Oximeter at Euroanaesthesia 2009
Devices Monitoring
 HSMN NewsFeed - 1 Jun 2009
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 May 2009
Cytori Completes Enrollment in First Adipose Stem & Regenerative Cell Therapy Trial for Chronic Heart Disease
Regenerative Medicine Cardiology
 HSMN NewsFeed - 20 May 2009
Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 May 2009
Molecular Insight Pharmaceuticals, Inc. Receives European Medicines Agency Approval to Proceed With Phase 3 Development of Onalta(TM)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 May 2009
The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 May 2009
Molecular Insight Pharmaceuticals Expands Management Team by Appointing Daniel L. Peters as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 May 2009
Enrollment Complete in the XCELL Trial - The First U.S. Study of Stent Placement to Study Arterial Blockages Below the Knee
Devices Interventional
 HSMN NewsFeed - 11 May 2009
Schering-Plough Starts Patient Enrollment in Phase 3 Trial for Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 May 2009
Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 28 Apr 2009
Prospera Reports Recent Advances in Negative Pressure Wound Therapy (NPWT) Research Presented at the SAWC in Dallas
Devices Wound Care
 HSMN NewsFeed - 20 Apr 2009
St. Jude Medical Announces European Approval of ICDs with Features That Automatically Enhance Patient Safety and Streamline Patient Follow-up
Devices Cardiology Regulatory
 HSMN NewsFeed - 13 Apr 2009
Arrow International Announces Worldwide Voluntary Recall of Intra Aortic Balloon Pump (IAB) Catheters
Devices Cardiology Product Recall
 HSMN NewsFeed - 9 Apr 2009
New Clinical Data at ACC09 Show the CYPHER Sirolimus-eluting Coronary Stent Outperformed TAXUS LIBERTE and ENDEAVOR Stents in Key Outcome Measures
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Apr 2009
Vasomedical Introduces BIOX Holter Monitoring Systems and Analysis Software
Devices Monitoring FDA
 HSMN NewsFeed - 1 Apr 2009
NIMS Exer-Rest(R) Technology Linked to Reduced Brain Damage in Strokes
Devices Neurology
 HSMN NewsFeed - 31 Mar 2009
Cardium's InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapy's Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
Devices Neurosurgery
 HSMN NewsFeed - 30 Mar 2009
St. Jude Medical and GE Healthcare Announce Worldwide Market Launch of Wireless Integrated FFR Solution
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Mar 2009
Toshiba Introduces Upgrades to the Aplio Artida to Enhance Imaging Capabilities for the Cardiac Market
Devices Cardiology
 HSMN NewsFeed - 24 Mar 2009
Ischemix Appoints Robert DuFresne as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2009
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Mar 2009
FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2009
Molecular Insight Receives Special Protocol Assessment Approval From FDA for Phase 2 Trial of Azedra(TM), a Radiotherapeutic to Treat Neuroendocrine Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Mar 2009
Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
Devices Urology Oncology
 HSMN NewsFeed - 2 Feb 2009
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2009
Pathway Medical Technologies Receives FDA 510(K) Clearance for Jetstream G2 System
Devices Interventional FDA
 HSMN NewsFeed - 30 Jan 2009
Diagnosoft(R) Introduces Its Third MRI Analysis Innovation
Devices Radiology Cardiology
 HSMN NewsFeed - 27 Jan 2009
Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
Biopharmaceuticals
 HSMN NewsFeed - 26 Jan 2009
Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Jan 2009
Volcano Highlights Commitment, Market Acceptance of FFR Product Line
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Jan 2009
Astro-Med's Grass Technologies Group Receives FDA Clearance to Market Its Neurotrac(R) III Neuromonitoring System
Devices Monitoring Neurology FDA
 HSMN NewsFeed - 15 Jan 2009
Cleveland Clinic to Present Results from Study Using Ivivi Technologies' tPEMF(tm) on Cardiac Ischemia At American College of Cardiology Annual Meeting
Devices Cardiology
 HSMN NewsFeed - 17 Dec 2008
Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Dec 2008
Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
Devices Urology
 HSMN NewsFeed - 15 Dec 2008
Cardium's InnerCool Awarded U.S. Supplier Agreement With Novation LLC
Devices Group Purchasing
 HSMN NewsFeed - 26 Nov 2008
Tarceva(R) (erlotinib) Endorsed by the U.K.'s National Institute for Health and Clinical Excellence for Use in Patients with Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Nov 2008
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
Devices Urology
 HSMN NewsFeed - 6 Nov 2008
Newly Published Data from Long-Term Study Show Neurostimulation Provides Sustained Leg Pain Relief, Improved Quality of Life and Functional Capacity
Devices Neurosurgery
 HSMN NewsFeed - 6 Nov 2008
FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 27 Oct 2008
UK's NICE Recommends Spinal Cord Stimulation for Patients with Chronic Neuropathic Pain
Devices
 HSMN NewsFeed - 20 Oct 2008
Cardium Announces FDA 510(K) Clearance of InnerCool's RapidBlue(TM) Endovascular System
Devices FDA
 HSMN NewsFeed - 15 Oct 2008
Volcano Corporation Announces Launch of PrimeWire(TM) Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
Radi Medical Systems AB and GE Healthcare Announce Cooperation to Integrate FFR and PressureWire(R) Aeris in GE Mac-Lab(R) IT
Devices Cardiology Monitoring
 HSMN NewsFeed - 30 Sep 2008
OrthoLogic Corp. Announces New Company Name: Capstone Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 22 Sep 2008
Molecular Insight Pharmaceuticals, Inc. Adds Four Healthcare Industry Experts to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2008
Pathway Medical Technologies Receives FDA Clearance for Jetstream(TM) Pathway PV(TM) Atherectomy System
Devices Interventional FDA
 HSMN NewsFeed - 3 Sep 2008
Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Sep 2008
New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 26 Aug 2008
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 Aug 2008
ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Aug 2008
OrthoLogic Announces Chrysalin (TP508) Demonstrates Significant Benefit in a Pre-Clinical Model of Acute Heart Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Aug 2008
NewCardio Names Ihor Gussak, M.D., Ph.D., FACC Chief Medical Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 28 Jul 2008
Ikaria(R) Receives FDA Orphan Drug Designation for Inhaled Carbon Monoxide for Delayed Graft Function in Solid Organ Transplants
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Jul 2008
Nexavar Approved for Liver Cancer in China
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 Jul 2008
Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
Devices Regulatory
 HSMN NewsFeed - 8 Jul 2008
Agile Therapeutics Appoints Senior Executive Jeffrey Frick as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2008
FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
Biopharmaceuticals Radiology FDA
 HSMN NewsFeed - 7 Jul 2008
Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Jul 2008
FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 23 Jun 2008
EyeCyte, Inc. Secures Series A Funding from Pfizer
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 19 Jun 2008
ThermoGenesis Announces Receipt of CE Mark for MarrowXpress (TM)
Devices Regenerative Medicine Regulatory
 HSMN NewsFeed - 4 Jun 2008
LifeWatch Corp. Parent Company, Card Guard AG Receives Full FDA Clearance for Next-Generation LifeStar ACT III Platinum System
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 2 Jun 2008
Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 1 Jun 2008
Updated REVLIMID(R) Data Presented in Newly Diagnosed Multiple Myeloma Presented at the 2008 American Society of Clinical Oncology (ASCO) Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 May 2008
Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield
Devices Interventional Cardiology
 HSMN NewsFeed - 28 May 2008
Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 May 2008
Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 May 2008
Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2008
ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2008
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisation or Death in Patients With Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 May 2008
XIENCE(TM) V Drug Eluting Stent from Abbott Reduces Major Adverse Cardiac Events in Small Vessel Patients Out to One Year
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Apr 2008
Cardium Reports on Science Channel Series Featuring InnerCool's Endovascular Cooling During Brain Surgery at Stanford University
Devices Neurosurgery
 HSMN NewsFeed - 23 Apr 2008
Aldagen Secures $18.4 Million in Financing
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 22 Apr 2008
Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Apr 2008
Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
Devices Cardiology
 HSMN NewsFeed - 11 Apr 2008
ALIMTA(R) (pemetrexed for injection) Receives European Approval for Histologically-Based Use in First-Line Treatment of Most Common Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 Apr 2008
Endo Pharmaceuticals Provides Updates on FROVA(R) and CHRONOGESIC(R) Clinical Development Programs
Biopharmaceuticals
 HSMN NewsFeed - 1 Apr 2008
CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 Apr 2008
Lipitor Provided an Unexpectedly Potent Heart Benefit in Patients with Chronic Stable Angina, According to New Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Mar 2008
King Pharmaceuticals Presents Positive Results of CorVue(TM) Phase III Clinical Trials at the American College of Cardiology (ACC) Annual Scientific Conference
Biopharmaceuticals Radiology Cardiology
 HSMN NewsFeed - 31 Mar 2008
Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Mar 2008
Abbott's XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Mar 2008
Cardium's InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
Devices Distribution
 HSMN NewsFeed - 11 Mar 2008
Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 26 Feb 2008
BSP's New Line of HyperQ Products: Bedside Ischemia Monitoring Systems Announces Successful Results of First Feasibility Study
Devices Monitoring
 HSMN NewsFeed - 25 Feb 2008
First Patient Enrolled in Study Evaluating Performance of Spectranetics Laser Ablation Followed by GORE VIABAHN(R) Endoprosthesis with Heparin Bioactive Surface
Devices Interventional
 HSMN NewsFeed - 20 Feb 2008
Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
Devices Interventional FDA
 HSMN NewsFeed - 18 Feb 2008
Bayer and Onyx Provide Update on Phase 3 Trial of Nexavar in Patients With Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Feb 2008
Pfizer Presents New Data from HIV/AIDS Portfolio at Conference on Retroviruses and Opportunistic Infections
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 6 Feb 2008
POINT Biomedical Corp. First Tranche of $50 Million in Equity Financing
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 1 Feb 2008
Abbott Gains Reimbursement for XIENCE(TM) V Drug Eluting Stent in France
Devices Reimbursement Interventional Cardiology
 HSMN NewsFeed - 30 Jan 2008
First Patients Treated in Cytori's Stem & Regenerative Cell Heart Attack Study
Regenerative Medicine Cardiology
 HSMN NewsFeed - 24 Jan 2008
Cook Incorporated Files IDE Application for Zenith Branch Vessel Graft with U.S. FDA
Devices Interventional FDA
 HSMN NewsFeed - 8 Jan 2008
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
Regenerative Medicine
 HSMN NewsFeed - 21 Dec 2007
TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 18 Dec 2007
Harvard University Completes Clinical Study of Pegasus HeartVue 6S System Heart Screening Device
Devices Cardiology
 HSMN NewsFeed - 18 Dec 2007
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Drug Delivery Wound Care
 HSMN NewsFeed - 14 Dec 2007
OSI Pharmaceuticals Announces Launch Date of Tarceva(R) (erlotinib) in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 Dec 2007
PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Dec 2007
Heartscape Technologies Appoints Former Medtronic Executive to Role as Chairman and Independent Director
Devices Personnel
 HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 19 Nov 2007
Nexavar First FDA-Approved Drug Therapy for Liver Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Nov 2007
Cardium and InnerCool Complete $5 Million Commercial Financing to Support Launch of New Product Lines
Devices
 HSMN NewsFeed - 14 Nov 2007
GSK Revises US Labeling for Avandia(R)
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 12 Nov 2007
Actelion: Pivlaz (Clazosentan) Phase III Study Initiated to Demonstrate Prevention of Vasospasm-Related Morbidity and All-Cause Mortality After Aneurysmal Subarachnoid Hemorrhage
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 6 Nov 2007
COURAGE Sub-study: PCI Outperforms Drugs-Only
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Nov 2007
CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36
Biopharmaceuticals Cardiology Endocrinology
 HSMN NewsFeed - 6 Nov 2007
Acusphere Announces Data Demonstrating Imagify(TM) Perfusion Stress Echo is Well-tolerated and as Effective as Nuclear Perfusion Imaging for Evaluating Chest Pain Patients at Risk for Heart Attack
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Nov 2007
Abbott Confirms FDA Advisory Panel to Review XIENCE(TM) V Drug Eluting Stent on November 29
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 5 Nov 2007
Ranexa(R) Significantly Reduces Incidence of CV Death, MI or Recurrent Ischemia in MERLIN TIMI-36 Patients With Elevated BNP
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 Nov 2007
Cytori Receives European Approval for 2nd Generation Celution(TM) Stem & Regenerative Cell Processing System
Devices Regenerative Medicine Regulatory
 HSMN NewsFeed - 30 Oct 2007
Nexavar Becomes First and Only Approved Treatment of Hepatocellular Carcinoma in Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 23 Oct 2007
Edwards' Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
Devices Interventional
 HSMN NewsFeed - 22 Oct 2007
Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
New Stem Cell Treatment Reduces Amputations in Critical Limb Ischemia (CLI)
Regenerative Medicine
 HSMN NewsFeed - 22 Oct 2007
InnerCool Licenses New Therapeutic for Potential Use in Stroke Patients
Devices Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 22 Oct 2007
Tarceva(R) (erlotinib) Earns Approval for Lung Cancer Patients in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 21 Oct 2007
Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 18 Oct 2007
Aastrom Stem Cell Therapy Demonstrates Positive Results in Severe Long Bone Non-Union Fracture Trial
Regenerative Medicine Orthoapedic
 HSMN NewsFeed - 16 Oct 2007
FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Oct 2007
Improved Perioperative Blood Pressure Control Associated with Reduced Risk of Kidney Dysfunction in Cardiac Surgery Patients
Biopharmaceuticals Cardiology Surgery
 HSMN NewsFeed - 15 Oct 2007
Biopure Announces Expanded Clinical Program To Target Anemia
Biopharmaceuticals
 HSMN NewsFeed - 10 Oct 2007
Multicenter PolyHeme Trauma Study Presented at the American College of Surgeons 93rd Annual Clinical Congress
Biopharmaceuticals
 HSMN NewsFeed - 9 Oct 2007
Spectranetics Receives Reimbursement Approval in Belgium for Lead Removal and Peripheral Atherectomy Products
Devices Interventional Reimbursement
 HSMN NewsFeed - 8 Oct 2007
FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
Devices Interventional FDA
 HSMN NewsFeed - 1 Oct 2007
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal(R) to OB/GYNs
Biopharmaceuticals
 HSMN NewsFeed - 27 Sep 2007
FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 25 Sep 2007
Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Sep 2007
New Device for Clearing Blocked Arteries in the Legs Receives FDA Clearance for Peripheral Use - Procedures Performed Across the US Within First 48 Hours
Devices Interventional FDA
 HSMN NewsFeed - 21 Sep 2007
Nexavar Receives Positive Opinion from European Committee for Medicinal Products for Human Use for Treatment of Liver Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 20 Sep 2007
Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
Biopharmaceuticals
 HSMN NewsFeed - 18 Sep 2007
Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug Selzentry(TM) (Maraviroc)
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 18 Sep 2007
OSI Pharmaceuticals Announces Patent Term Extension for Tarceva(R) (erlotinib)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Sep 2007
Aldagen Raises Additional $9 Million, Increasing Series C Financing to $23 Million
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 13 Sep 2007
The Society of Thoracic Surgeons Adds Cerebral Oximetry as Metric to STS Adult Cardiac Surgery Database
Devices Monitoring Surgery
 HSMN NewsFeed - 7 Sep 2007
OSI Pharmaceuticals Summarizes Data Presented on Tarceva(R) (erlotinib) at the 12th World Congress on Lung Cancer Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Sep 2007
Biopure Reports on Meeting with the FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Sep 2007
New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Aug 2007
BioLineRx In-Licenses Novel Drug for the Treatment of Acute Kidney Injury
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Aug 2007
Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Aug 2007
Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Aug 2007
PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 20 Aug 2007
Nexavar Granted FDA Priority Review for Treatment of Liver Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Aug 2007
Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa in Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Aug 2007
Pfizer's SelzentryTM (Maraviroc) Tablets, Novel Treatment for HIV, Approved by FDA
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 30 Jul 2007
GlaxoSmithKline Presents Avandia Data To FDA
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 27 Jul 2007
Positive Aggrastat(R) Results Versus Integrilin(R) Featured in American Heart Journal
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 24 Jul 2007
CoAxia(TM) Announces First Use of NeuroFlo(TM) Technology in Study for Stroke Patients After Attempted Thrombolysis
Devices Neurology Interventional
 HSMN NewsFeed - 19 Jul 2007
Schering-Plough Announces Licensing of Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 18 Jul 2007
FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 12 Jul 2007
Barr Confirms Patent Challenge of Aggrenox(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 11 Jul 2007
J. William Freytag, PH.D. appointed Chairman and Chief Executive Officer of Aspreva Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2007
Ivivi Technologies Announces Completion of Patient Enrollment for its Cardiac Clinical Trial at The Cleveland Clinic Florida
Devices Cardiology
 HSMN NewsFeed - 27 Jun 2007
First Patient Treated in Aastrom Adult Stem Cell Trial for Critical Limb Ischemia
Regenerative Medicine
 HSMN NewsFeed - 27 Jun 2007
Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Jun 2007
Bayer and Onyx Submit New European Marketing Authorization Application to EMEA for Nexavar to Treat Liver Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 Jun 2007
New Balloon Catheter Available Worldwide for Carotid and Renal Angioplasty Procedures
Devices Interventional
 HSMN NewsFeed - 5 Jun 2007
OSI Pharmaceuticals Summarizes Data on Tarceva(R) (erlotinib) at the 2007 American Society of Clinical Oncology (ASCO) Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Jun 2007
Health Canada's approval of an expanded indication for PLAVIX(R) (clopidogrel bisulfate) now offers protection from all types of heart attacks
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 4 Jun 2007
ONTAK(R) (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jun 2007
Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2007
Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2007
Phase III Study Shows Avastin Plus Interferon Therapy Nearly Doubled Median Progression-Free Survival in Patients With Previously Untreated Advanced Kidney Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 May 2007
CoAxia(TM) Announces First Patients Enrolled in Study Extending Treatment for Acute Stroke Up to 24 Hours
Devices Neurology Interventional
 HSMN NewsFeed - 30 May 2007
Neuralstem's Cells Restore Motor Function in Spinal Ischemia-Paralyzed Rats
Regenerative Medicine
 HSMN NewsFeed - 22 May 2007
Abbott Announces Continued Positive Results with XIENCE(TM) V Everolimus Eluting Coronary Stent in SPIRIT Clinical Trials
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2007
Five-Year Fractional Flow Reserve Data Confirms Benefit of Deferral of Stenting
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2007
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 17 May 2007
Molecular Insight Pharmaceuticals, Inc. Enters into Agreement to Purchase Radiopharmaceutical Manufacturing Facility
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2007
Positive Statistical Analysis from Synthetic Blood's Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 May 2007
CV Therapeutics Submits New Drug Application For Regadenoson
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 10 May 2007
Molecular Insight Pharmaceuticals, Inc. Initiates Azedra(TM) Therapeutic Trial in Neuroendocrine Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 May 2007
Amorcyte Cardiac Cell Therapy Trial Completes Second of Four Phases
Regenerative Medicine Cardiology
 HSMN NewsFeed - 7 May 2007
FDA Approves Aastrom Phase III IND for Treatment of Osteonecrosis of the Femoral Head
Regenerative Medicine Orthopaedic
 HSMN NewsFeed - 2 May 2007
Y's Therapeutics Initiates Phase II Trial With YSPSL in Liver Transplant Patients for Prevention of Ischemic Reperfusion (I/R) Injury
Biopharmaceuticals
 HSMN NewsFeed - 30 Apr 2007
Aastrom Initiates Adult Stem Cell Clinical Trial for Peripheral Arterial Disease
Regenerative Medicine FDA
 HSMN NewsFeed - 26 Apr 2007
Two-year data for Angiotech's Vascular Wrap(TM) Paclitaxel-Eluting Mesh to be presented at European vascular symposium
Devices
 HSMN NewsFeed - 25 Apr 2007
OSI Pharmaceuticals Announces Pivotal Phase III Tarceva(R) Study Published in the Journal of Clinical Oncology Showed Survival Improvement in Patients with Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Apr 2007
Heartscape Technologies Announces Close of Series B Funding
Devices Cardiology Venture Capital
 HSMN NewsFeed - 24 Apr 2007
Journal of the American Medical Association Publishes MERLIN TIMI-36 Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 23 Apr 2007
Molecular Insight Pharmaceuticals, Inc. Announces Appointment of Norman LaFrance, M.D., as Senior Vice President, Clinical Development and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Apr 2007
QuantRx(R) Biomedical Acquires Majority Interest in FluoroPharma
Diagnostics Cardiology
 HSMN NewsFeed - 18 Apr 2007
Molecular Insight Pharmaceuticals, Inc. Announces Appointment of Brian Abeysekera, Ph.D., as Vice President, Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2007
COURAGE, SPIRIT Data May Support Role of Advanced Imaging and Diagnosis With IVUS and FFR
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Apr 2007
Lilly Oncology Focused on Pharmacogenomics at AACR Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Apr 2007
Molecular Insight Pharmaceuticals, Inc. Announces Resignation of Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2007
Possis Receives New FDA Approval for Spiroflex(R) VG Catheter
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 27 Mar 2007
Pivotal Phase III Findings With Investigational Drug Cleviprex(TM) (Clevidipine) Demonstrate Perioperative Blood Pressure Control In Cardiac Surgery
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Mar 2007
Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Mar 2007
Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa in Metastatic Brain Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Mar 2007
ACUITY One-Year Findings Meet All Primary Endpoints in Favor of Angiomax(R) (Bivalirudin) Alone Treatment Group
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 26 Mar 2007
New Study Indicates Nicotine Patches May be Safe for Helping Patients with Coronary Artery Disease to Quit Smoking
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 26 Mar 2007
CryoPlasty(R) Provides Alternative to Amputation For Patients With Blocked Arteries Below The Knee
Devices Interventional
 HSMN NewsFeed - 25 Mar 2007
KAI Pharmaceuticals Presents Encouraging Phase 1/2 Results of a Novel Treatment for Heart Attack
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2007
Spirit III Clinical Trial Demonstrates Positive Performance for Both TAXUS(R) and PROMUS(TM) Drug-Eluting Stent Systems
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2007
Abbott Announces Positive Six-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Mar 2007
First Patient Enrolled in RAPID MI-ICE Study Employing InnerCool's Endovascular Temperature Modulation Therapy for Heart Attack
Devices Cardiology
 HSMN NewsFeed - 20 Mar 2007
Cordis Corporation to Emphasize Commitment to Interventional Cardiology at ACC.07
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Mar 2007
Boston Scientific Announces Schedule for ACC 2007
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Mar 2007
Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa(TM) in Brain Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Mar 2007
CV Therapeutics Announces Topline MERLIN TIMI-36 Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Feb 2007
ARYx Therapeutics Appoints New Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2007
TaiGen Appoints Dr. Luke Lin VP of Clinical Research & Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Feb 2007
Nexavar Shown to Significantly Extend Survival for Patients with Advanced Liver Cancer
Biopharmaceuticals Oncology
Return to NewsFeed  

 Additional items found! 318

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 318 additional stories matching:
ischemia
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!